Study of Nivolumab for Advanced Cancers in India

NCT03444766 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer (NSCLC)
Non-Small-Cell Lung Carcinoma
Nonsmall Cell Lung Cancer
Kidney Cancer
Kidney Neoplasms
Renal Cancer
Renal Neoplasms

Interventions

DRUG: Nivolumab

Sponsor

Bristol-Myers Squibb